HEERLEN, THE NETHERLANDS — Royal DSM is partnering with Broomfield, Colo.-based cannabinoid ingredients and finished products manufacturer Mile High Labs to develop new hemp-derived cannabinoid solutions.
The partnership will see DSM combine CBD and hemp derivatives with micronutrients to create a variety of market-ready and premix solutions.
“There is a strong consumer pull in the CBD space for high-quality, health-benefit driven solutions, but as yet the market is still to arrive at recognized science or quality standards,” said Frederic Boned, vice president of human nutrition and health at DSM North America. “DSM has the core competencies to help brands enter the cannabinoid market early and build a leading position.”
